Dr. Danielle S. McDermott, MD

Dr. McDermott practices at Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority.

Dr. McDermott's NPI, 1619139243, was assigned on June 25, 2008. Dr. McDermott graduated from University of Colorado School of Medicine, Denver in 2007. Dr. McDermott holds Colorado license DR.0049725.

Dr. McDermott's primary practice is Denver Health Medical Center, at 777 Bannock St, Denver, CO 80204 in Denver County. The practice phone is (303) 602-4935.

Dr. McDermott's primary practice is Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority. The medical group on file is Denver Health. Dr. McDermott's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDermott practices. Vendor and product names are available with a free account.

Epilepsy is Dr. McDermott's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. McDermott is licensed in Colorado.

CMS data shows 31 Medicare services from Dr. McDermott across 1 procedure code in 2021, all of them office visits, for 26 Medicare patients. Medicare paid $3,355 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. McDermott in 2024. 69% of them have high blood pressure, and 54% have alzheimer's and dementia. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McDermott's median patient age at 62, with 63% women.

In 2024, Dr. McDermott wrote 137 Medicare Part D claims for 26 patients. 77% of them were for generic drugs. CMS names the drug for 83 of them, across 4 drugs with 11 or more claims each, at $19,687 in total drug cost. In 2021, CMS named 296 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. McDermott for performance year 2024, reported as part of a group. Dr. McDermott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. McDermott, published from 2020 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Drug Resistant Epilepsy, Epilepsy and Brain. Dr. McDermott has published most often in Epilepsy Behav. Dr. McDermott's most frequent co-authors are Mesha-Gay M. Brown, MD, Aviva Abosch, MD and Steven G. Ojemann, MD.

CMS Open Payments shows 127 general payments to Dr. McDermott from 13 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 68% of the total. SK Life Science, Inc. paid the most, $26,175.

Dr. McDermott graduated from University of Colorado School of Medicine, Denver in 2007.